Ads
related to: latest treatments for rheumatoid arthritis disease burden- Find A Rheumatologist
Find A Rheumatologist Near You.
Set Goals For RA Treatment.
- See Treatment Results
Help Relieve Your RA Symptoms
With A Once-Daily Oral Pill.
- RAPID3 Calculator
Take A Short, Simple Questionnaire
To Help Your Doctor Assess Your RA.
- Injection-Free Treatment
RA TNF Blocker Didn't Work For You?
See How A JAK Inhibitor May Help.
- Find A Rheumatologist
Search results
Results From The WOW.Com Content Network
Conventional DMARDs are known to be the first-line treatment for rheumatoid arthritis. [9] Treatment can be a monotherapy or in combination with other anti-arthritic medications. Common DMARDs include oral methotrexate, leflunomide, or sulfasalazine. Conventional DMARDs have a slow onset of action and can take 2–3 months to exhibit effect. [9]
As of 2020, about 17.6 million people globally were living with rheumatoid arthritis, an autoimmune disease causing painful inflammation and swelling in joints. Scientists are still not sure as to ...
Sulfasalazine also appears to be most effective in the short-term treatment of rheumatoid arthritis. [126] Hydroxychloroquine, in addition to its low toxicity profile, is considered effective for treatment of moderate RA symptoms. [127] Agents may be used in combination, however, people may experience greater side effects.
Although the use of the term DMARDs was first propagated in rheumatoid arthritis (hence their name), the term has come to pertain to many other diseases, such as Crohn's disease, lupus erythematosus, Sjögren syndrome, immune thrombocytopenic purpura, myasthenia gravis, sarcoidosis, and various others. [citation needed]
Rheumatologists treat arthritis, autoimmune diseases, pain disorders affecting joints, and osteoporosis. [3] There are more than 200 types of these diseases, including rheumatoid arthritis, osteoarthritis, gout, lupus, back pain, osteoporosis, and tendinitis. Some of these are very serious diseases that can be difficult to diagnose and treat.
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).
Ads
related to: latest treatments for rheumatoid arthritis disease burden